Skip to main content

LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE)

Agency: National Institutes of Health

Assistance Listings
  • 93.855 -- Allergy and Infectious Diseases Research

Forecasted opportunityLast Updated: Sep 24, 2026

Important dates

  • Forecasted post date: July 20, 2027
  • Forecasted application due date: October 18, 2027
  • Forecasted award date: July 1, 2028
  • Forecasted project start date: July 1, 2028
  • Fiscal Year: 2028

Award details

  • Expected project funding: Not specified
  • Expected awards: 10

Award min.

Not specified

Award max.

Not specified

  • Funding opportunity number:RFA-AI-28-015
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Cooperative agreement
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: September 24, 2026
  • Archive date: Not specified
  • Version: 1

View version history on Grants.gov

Summary

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission through the LeverAging StraTegies to Maximize ImpLementation and Effectiveness for HIV (LAST MILE) program. This program will encourage collaborations to perform effectiveness trials that incorporate implementation in real-world settings. Examples include combined efficacy-effectiveness trials, pragmatic trials, and hybrid effectiveness-implementation studies. The intent is to bridge findings from traditional clinical trials to real-world implementation. The work will focus on populations across various points of care for prevention or treatment of HIV and its associated coinfections and comorbidities occurring in any age group. The goal of this program is to advance cross-cutting areas of HIV research, including clinical, behavioral and social sciences, epidemiology, and implementation science. This program aligns with the NIH mission to implement advances in HIV/AIDS research. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. 

Eligibility

Business

  • For-profit organizations other than small businesses
  • Small businesses

Government

  • Special district governments
  • Federally recognized Native American tribal governments
  • County governments
  • State governments
  • City or township governments
  • Public and Indian housing authorities

Education

  • Public and state institutions of higher education
  • Private institutions of higher education
  • Independent school districts

Nonprofit

  • Nonprofits non-higher education without 501(c)(3)
  • Other Native American tribal organizations
  • Nonprofits non-higher education with 501(c)(3)

Miscellaneous

  • Other

Additional information on eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Documents

No documents are currently available.

Agency contact information

Email: EB@niaid.nih.gov

EB@niaid.nih.gov

Division of AIDS Epidemiology Branch, Basic Sciences Program Please contact via e-mail.

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov